Medicine and Health Sciences Commons^™

Persistent Poverty And Incidence-Based Melanoma Mortality, Tiffaney Tran, Karla Madrigal, Lillian Morris, Kehe Zhang, Emelie Nelson, Marcita Galindez, Zhigang Duan, Adewole S. Adamson, Hui Zhao, Hung Q. Doan, Madison M. Taylor, Cici Bauer, Kelly C. Nelson

Gulf Coast Division GME Research Symposium 2024

No abstract provided.

Skin Cancer, Skin Biopsies And Mohs Surgery: Patient Education, Negar Esfandiari

Family Medicine Clerkship Student Projects

Skin cancer is the most common cancer in the United States. There are three main types of skin cancer: Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma. While Melanoma is less common than Basal Cell and Squamous Cell Carcinoma, it has a higher mortality rate. If diagnosed in earlier stages, Melanoma has a significantly better prognosis and lower patient costs. Most skin cancers are diagnosed through skin biopsies. Vermont has one of the highest rates of skin cancer. The goal of this project was to develop a patient handout to bring patient awareness to skin cancer and describe the different …

Acral Lentiginous Melanoma: A Rare Variant With Unique Diagnostic Challenges, Taylor Gray, Brett Brazen, Maheera Farsi, Richard Miller

West Florida Division GME Research Day 2020

Acral lentiginous melanoma (ALM), named for its location and histological growth pattern, is a rare variant of melanoma. ALM presents on palms, soles, or in association with the nail unit.1 While ALM accounts for approximately 5% of melanomas diagnosed each year, it is the most commonly diagnosed subtype of melanoma in non-Caucasian patients.

Sun-Safety: Assessing Barriers And Promoting Sun-Safe Practices For Vermonters., Joy A. Benner

Family Medicine Clerkship Student Projects

Skin cancer continues to be the most common cancer in Vermont and the United States. About one in five Americans will develop skin cancer in their lifetime. Vermont currently ranks second highest in the country for melanoma skin cancer rates. Rates continue to rise and skin cancer is impacting patients at younger and younger ages. Although several factors play into development of melanoma, a large risk factor for developing skin-cancer in one's lifetime is UV exposure. One way to combat this is to encourage regular sun-safe practices, such as daily sunscreen use, seeking shade, and wearing sun-protective clothing. The aim …

Melanoma Surveillance, Samuel Logan

Family Medicine Clerkship Student Projects

According to the CDC, in 2015 the rate of melanoma of the skin was 22.1 per 100 thousand people, the sixth most common cancer. In Vermont this rate was 35.8 per 100 thousand, higher than the national average. In Berlin, VT, it was noted that patients often are concerned about their nevi, but often do not know when it is appropriate to bring them to their physician's attention. A pamphlet was developed to assist physicians in educating patients on the characteristics of melanocytic nevi and encourage patients to speak to their physician when they find moles which meet these characteristics.

Oncolog, Volume 63, Number 04, April 2018, Joe Munch, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

• Hunger Training Helps Manage Weight, May Reduce Cancer Risk: Clinical Trial tests weight loss strategy to reduce cancer risk in obese participants
• Re-Irradiation for Recurrent Head and Neck cancer: Stereotactic techniques enable re-irradiation of unresectable tumors
• Dermoscopy for Early Detection of Melanoma. Other Skin Cancers: MD Anderson physicians train clinicians in underserved areas to use dermoscopy, which can help avoid unnecessary biopsy
• HOUSE CALL: Alcohol-Related cancers-Drinking alcohol increases risk of several types of cancer

Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
• Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
• Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
• HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue

Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed

OncoLog MD Anderson's Report to Physicians (All issues)

• Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
• Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
• INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
• HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
• USEFUL RESOURCES: Resources to Aid Referring Physicians

Oncolog, Volume 61, Number 04, April 2016, Joe Munch, Bryan Tutt, K Werner

OncoLog MD Anderson's Report to Physicians (All issues)

• Aggressive Multimodality Salvage Therapy for Locally Recurrent Rectal Cancer Offers Hope to Patients: For patients with locally recurrent rectal cancer, multimodality salvage therapy presents the only chance for a cure. Such therapy is offered at just a handful of specialized referral institutions, including The University of Texas MD Anderson Cancer Center.
• Rapid Assessment, Clinical Trials Could Improve Outcomes for Anaplastic Thyroid Cancer Patients: Anaplastic thyroid cancer is extremely aggressive-only 20% of patients survive 1 year after their diagnosis-so patients require immediate assessment and treatment. A program at The University of Texas MD Anderson Cancer Center expedites the care of patients …

Skin Cancer Prevention, Jameson T. Loyal

Family Medicine Clerkship Student Projects

The state of Vermont has one of the highest incidences of skin cancer, and in particular melanoma, in the entire country. In fact, melanoma is the fifth most common cancer diagnosed in Vermont. The purpose of this project is to determine the impact of skin cancer on the state of Vermont and to develop a patient-centered educational brochure in which to educate patients on skin cancer and ways to prevent it. Through interviews with subject experts it is clear that one of the best ways to prevent skin cancer is through education. The informational brochure on skin health met a …

Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair

OncoLog MD Anderson's Report to Physicians (All issues)

• New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
• Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
• INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
• HOUSE CALL: Prostate Cancer Screening-Who should …

Oncolog, Volume 60, Number 04, April 2015, Jill Deisigne, Joe Munch, Bryan Tutt, Sarah Bronson

OncoLog MD Anderson's Report to Physicians (All issues)

• Multidisciplinary Globe-Sparing Treatment for Lacrimal Gland Carcinoma Preserves Vision and Minimizes Morbidity: Until recently, the treatment of lacrimal gland carcinoma almost always required removal of the eye. But for some patients with these tumors, globe-sparing surgery followed by radiation therapy can preserve vision and decrease ocular morbidity and facial disfigurement.
• Novel Trial Design Streamlines Development of Breast Cancer Therapies: Developing a cancer-fighting drug can take around a billion dollars and a dozen or more years. Even then, fail in clinical trials. To identify effective cancer therapies more quickly and efficiently, researchers have tuned to an innovative clinical model in which …

Creating An Effective Education Pamphlet On Sun Protection And Skin Cancer Prevention, Alexandra E. Brown

Family Medicine Clerkship Student Projects

Melanoma and other skin cancers are increasing in incidence in the United States. In Connecticut, the melanoma rate is higher than the national average. The public health cost of skin cancer treatment ranges from $2-$8 billion annually. The costs to the individual are also high and the diagnosis of an advanced stage cancer is always emotionally challenging for a patient and his/her family. Efforts should be aimed at primary and secondary prevention of skin cancer, and patient education is an important element of this goal. The creation and use of patient education pamphlets can help to increase patient awareness of …

Oncolog, Volume 57, Number 03, March 2012, Zach Bohannan, Sarah Bronson, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Precision Robotic Tools Facilitate Minimally Invasive Prostectomy: Surgeons face a treacherous landscape when they perform a proctectomy
• Fluorescence Cystoscopy Detects Hard-to-Find Bladder Tumors: Fluorescence cystoscopy, although not yet widely used in United States, has been shown to be effective for detecting tumors in the bladder that might not be visible with standard cystoscopy
• New HPV Vaccine Recommendations Could Have Multiple Benefits: New recommendations for vaccination against human papillomavirus (HPV) are intended to prevent cervical cancer but may also decrease the incidence rates of other cancers
• HOUSE CALL: Tanning Beds Pose Health Risks: Dangers of tanning range from wrinkled skin to …

Oncolog, Volume 56, Number 01, January 2011, Bryan Tutt, Sunni Hosemann

OncoLog MD Anderson's Report to Physicians (All issues)

• New Drug Control Symptoms of Myeloproliferative Disorders and Improve Quality of Life for Patients: Recent clinical trials have demonstrated that a new class of drugs can effectively treat myeloproliferative disorders
• Compass: Metastatic Melanoma: Experimental treatments could be preferable to standard therapies for metastatic melanoma
• HOUS CALL: Breast Awareness: Guidelines recommend breast awareness rather than formal self-exams

Oncolog Volume 55, Number 08, August 2010, Bryan Tutt, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

• Therapeutic Vaccines against Cancer: Clinical trials of thrapeutic vaccines in cancer patients yield positive results
• Findings Could Altere Chronic Myelogenous Leukemia Treatment: Phase III trials show newer drugs yield better responses than imatinib
• INBRIEF: Vandetanib Shows Benefit When Combined with Docetaxel for Lung Cancer/ HPV-Positive Tumor Status Indicates Better Prognosis in Patients with Oropharyngeal Cancer
• HOUSE CALL: Understanding the Benefits and Risks of Massage

Oncolog Volume 55, Number 06, June 2010, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

• The BATTLE Results Are IN: Phase II trial reveals molecular signatures in lung cancer that may guide treatment decisions.
• Endoscopic Repair of Colon Perforations: Nonsurgical techniques for closing gestrointestinal defects may yiels benefits for patients undergoing colonoscopy.
• INBRIEF: Stem Cells Seen Repairing Heart Attack Damage Over Time/Additional Blood Data May Improve Pediatric Leukemia Predictions/Pediatric Patients with Rare Tumor May benefit from Heated Chemotherapy/New Findings Refute Link Between UVA, Melanoma.
• HOUSE CALL: Skin Cancer Screening: What is It and Who Should Get It ?: Types of skin cancer/Who should be screened ?/What to expect/Self-examination: Check your skin regularly and tell your …

Oncolog Volume 54, Number 07/08, July/August 2009, John Lebas, Sunni Hosemann, Bryan Tutt

OncoLog MD Anderson's Report to Physicians (All issues)

• Frontiers in Radiosurgery
• Advanced Ovarian Cancer
• House Call: Colorectal Cancer: Life-Saving Options for Early Detection
• Reduced Wait Times Mean Faster Access for New Patients

Oncolog Volume 54, Number 05, May 2009, John Lebas

OncoLog MD Anderson's Report to Physicians (All issues)

• Targeting Inflammation in Cancer Prevention
• Treating Radiation Necrosis of the Brain
• Preclinical Studies Reveal Effectiveness of Therapies for Pediatric Cancers
• House Call: Protect and Check Your Skin

Oncolog Volume 51, Number 01, January 2006, Stephanie P. Deming, Diane Witter

OncoLog MD Anderson's Report to Physicians (All issues)

• Fertility After Cancer
• Improving the Odds in Lung Cancer
• House Call: Understanding the Basics of Melanoma

Oncolog Volume 53, Number 06, June 2008, Karen Stuyck, Virginia M. Mohlere, David Stouter, David Jenkins

OncoLog MD Anderson's Report to Physicians (All issues)

• Psychotherapy Extends Cancer Care Beyond the Physical
• House Call: Understanding How Cancer Spreads
• DiaLog: Teaming Spiritual and Medical Care, by Rev. David Stouter, Chaplain, Department of Chaplaincy and Pastoral Education, and Rev. David Jenkins, Director, Department of Chaplaincy and Pastoral Education
• Radical Trachelectomy: A Fertility-Sparing Option for Invasive Cervical Cancer

Oncolog, Volume 52, Number 03, March 2007, Sunni Hosemann, Karen Stuyck, Elizabeth L. Travis Phd

OncoLog MD Anderson's Report to Physicians (All issues)

• New Approaches for Advanced Melanoma
• Helping Patients Stop Smoking
• House Call: Simple Skin Cancer Prevention
• DiaLog: Toward Gender Equity in Academic Medicine, by Elizabeth Travis, PhD, Associate Vice President, Women Faculty Programs

Oncolog Volume 51, Number 03, March 2006, Dawn Chalaire, Martha Morrison

OncoLog MD Anderson's Report to Physicians (All issues)

• What Happens Next? Managing the Care of Long-Term Cancer Survivors
• House Call: Relieving Symptoms with Acupuncture
• 50 Years of OncoLog

Oncolog, Volume 49, Number 07/08, July/August 2004, Dawn Chalaire, David Galloway, Ellen Manzullo Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Proton Therapy Comes into Its Own
• Treating Patients with Cancer Requires Looking Beyond the Tumor
• House Call: Protecting Yourself Against Skin Cancer
• DiaLog: Treating Cancer-Related Fatigue, by Ellen Manzullo, MD, FACP, Department of General Internal Medicine, Ambulatory Treatment, and Emergency Care

Oncolog, Volume 48, Number 09, September 2003, Katie Prout Matias, David Galloway, Jeffrey E. Lee Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Sentinel Lymph Node Biopsy: Detection of Micrometastases Leads to More Precise Staging of Breast and Melanoma Tumors
• Sentinel Lymph Node Biopsy Shows Promise in Eye and Colon Cancers
• New Research Promotes a More Dynamic View of Adult Stem Cell Differentiation: Hematopoietic Stem Cells May One Day Be Used to Repair Tissue Damage Caused by Radiation Therapy or Chemotherapy
• House Call: Understanding the Buzz over Stem Cells
• DiaLog: Directed Parathyroid Surgery, by Jeffrey E. Lee, MD, Professor, Department of Surgical Oncology

Oncolog, Volume 47, Number 03, March 2002, Vickie J. Williams, Michael Worley, Noelle Heinze, Richard J. Babaian Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Largest-Ever Cancer Prevention Study to Examine the Effects of Selenium and Vitamin E on Prostate Cancer Occurrence
• Protocols: Prostate Cancer Clinical Trials
• House Call: Understanding Metastasis
• DiaLog: The Prostate--Specific Antigen Test: Reliability and Recommended Use, by Richard J. Babaian, MD, Professor, Department of Urology
• Trouble Spots: Early Detection Is Key to the Successful Treatment of Melanoma

Oncolog, Volume 46, Number 02, February 2001, Sunni Hosemann, Kerry L. Wright, Janet M. Bruner Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Specialized Training and Techniques of Pathologists Lead to Targeted Therapies
• Protocols: Studies Examine High-Dose Chemotherapy for Breast Cancer
• High-Dose Chemotherapy for Breast Cancer: Completion of Clinical Trials Necessary
• DiaLog: Many Specialties, One Goal, by Janet M. Bruner, MD, Chairman, Department of Pathology
• House Call: Support Groups Offer Patients a Helping Hand
• Study Reveals Types of Diagnostic Errors and Their Costs

Oncolog, Volume 46, Number 01, January 2001, Kerry L. Wright, Dawn Chalaire, Emil J. Freireich Md

OncoLog MD Anderson's Report to Physicians (All issues)

• New Melanoma Staging System Reflects Key Prognostic Factors
• House Cell: Preventing Cancer: Food for Thought
• Educational Conferences Explore Issues Related to Cancer Care and Research
• DiaLog: Leukemia: Setting the "Stage" for Effective Treatments, by Emil J. Freireich, MD, Professor, Department of Leukemia
• Updated M. D. Anderson Website Designed to Meet the Online Needs of Patients and Physicians

Oncolog, Volume 45, Number 06, June 2000, Kerry L. Wright, Margaret E. Goode, Jack Roth Md, Gary S. Clayman Md, Dds

OncoLog MD Anderson's Report to Physicians (All issues)

• Newly Organized Ophthalmology Section Expands Treatment of Ocular Malignancies
• Turning Knowledge Into Effective Gene Therapies, by Jack A. Roth, MD, Professor, Department of Thoracic and Cardiovascular Surgery, and Gary S. Clayman, MD, DDS, Associate Professor, Head and Neck Surgery
• Microarrays Reduce Time, Labor, and Cost of DNA Analysis
• New DNA Microarray Technology Could Speed Up Discovery of the Genetic Causes of Lung Cancer
• House Call: Virtual Health: Finding Reliable Medical Resources on the Internet
• Clinical Practice Guidelines: Case Report: Ovarian Cancer
• Protocols: Studies Aim to Detect and Treat Ocular Malignancies

Oncolog, Volume 45, Number 05, May 2000, Kerry L. Wright, Stephanie Deming, Gordon B. Mills Md, Phd

OncoLog MD Anderson's Report to Physicians (All issues)

• Early Detection of Melanoma Spread May Increase Survival Benefits of Adjuvant Therapy
• No Easy Answers: Women at Increased Risk for Breast Cancer Face Difficult Choices
• DiaLog: Understanding Risk: A Prerequisite for Making Informed Decisions, by Gordon B. Mills, MD, PhD, Chairman, Department of Molecular Therapeutics
• House Call: Looking for Trouble: How to Spot Signs of Melanoma
• Protocols: Melanoma Clinical Trials
• Biochemotherapy Means Hope for Patients with Advanced Melanoma